Shareholding disclosure

Kuros Biosciences AG

Declared position

85.27%

Threshold

Crossed downwards

Timeline

Published

13.04.2019

Transaction

08.04.2019

Voting rights breakdown

Voting rights acquired0.11%

Voting rights sold85.27%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAJ4B00060

Beneficial owner

Kuros Biosciences AG

Declared address

Kuros Biosciences AG, 8952 Schlieren

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kuros Biosciences AG

Kuros Biosciences AG13.04.2019TAJ4B00060

Disclosure summary

Kuros Biosciences AG disclosed a holding in Kuros Biosciences AG on the disposal side, published by SIX Exchange Regulation on 13.04.2019, at 85.27% of voting rights. Notice category: Single shareholder.

Disclosed position

85.27%

Voting rights sold

Voting rights acquired0.11%

Voting rights sold85.27%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Kuros Biosciences AG disclosed a holding in Kuros Biosciences AG, published on 13.04.2019.

Publication date13.04.2019

Transaction date08.04.2019

Issuing companyKuros Biosciences AG

Beneficial ownerKuros Biosciences AG

Declared addressKuros Biosciences AG, 8952 Schlieren

CategorySingle shareholder

Voting rights acquired0.11%

Voting rights sold85.27%

Below threshold0%

ExchangeXSWX

Notification IDTAJ4B00060

Commercial register

CHE-104.785.642

Registered

Zefix record

Source: SIX Exchange Regulation · Publication date: 13.04.2019

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open